These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 32572532)

  • 1. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
    Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
    Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients.
    Feys S; Carvalho A; Clancy CJ; Gangneux JP; Hoenigl M; Lagrou K; Rijnders BJA; Seldeslachts L; Vanderbeke L; van de Veerdonk FL; Verweij PE; Wauters J
    Lancet Respir Med; 2024 Sep; 12(9):728-742. PubMed ID: 39025089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.
    Krifors A; Blennow O; Påhlman LI; Gille-Johnson P; Janols H; Lipcsey M; Källman J; Tham J; Stjärne Aspelund A; Ljungquist O; Hammarskjöld F; Hällgren A; De Geer L; Lemberg M; Petersson J; Castegren M
    Infect Dis (Lond); 2024 Feb; 56(2):110-115. PubMed ID: 37897800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
    Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID-19-associated pulmonary aspergillosis: Cross-sectional and systematic review of literature.
    Dos Santos AP; Amorim BC; da Silva DG; de Rodrigues DKB; da Costa Marques AP; Gasparoto ALDB; da Costa Alvarenga de Brito E; Fava WS; de Oliveira CTF; Canassa AL; Gonçalves CCM; Grande AJ; de Souza Carvalho Melhem M; Paniago AMM; Volpe-Chaves CE; Venturini J
    Mycoses; 2024 Aug; 67(8):e13789. PubMed ID: 39179520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
    Flikweert AW; Grootenboers MJJH; Yick DCY; du Mée AWF; van der Meer NJM; Rettig TCD; Kant MKM
    J Crit Care; 2020 Oct; 59():149-155. PubMed ID: 32674001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
    Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
    Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
    Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
    J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.
    Peral J; Estella Á; Nuvials X; Rodríguez A; Seijas I; Soriano C; Suberviola B; Zaragoza R
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.
    Blaize M; Mayaux J; Nabet C; Lampros A; Marcelin AG; Thellier M; Piarroux R; Demoule A; Fekkar A
    Emerg Infect Dis; 2020 Jul; 26(7):1636-1637. PubMed ID: 32343223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
    Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 associated pulmonary aspergillosis.
    Koehler P; Cornely OA; Böttiger BW; Dusse F; Eichenauer DA; Fuchs F; Hallek M; Jung N; Klein F; Persigehl T; Rybniker J; Kochanek M; Böll B; Shimabukuro-Vornhagen A
    Mycoses; 2020 Jun; 63(6):528-534. PubMed ID: 32339350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report.
    Schein F; Munoz-Pons H; Mahinc C; Grange R; Cathébras P; Flori P
    J Mycol Med; 2020 Dec; 30(4):101039. PubMed ID: 32861584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
    Sasoni N; Rodriguez Müller M; Posse G; González J; Leonardelli F; Garcia-Effron G
    Rev Iberoam Micol; 2021; 38(1):16-18. PubMed ID: 33500209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
    Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
    Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.